Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Globus Medical Inc shares valued at $2,251,203 were sold by Davidar David D on Oct 16 ’24. At $75.04 per share, Davidar David D sold 30,000 shares. The insider’s holdings dropped to 536,275 shares worth approximately $39.44 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Davidar David D sold 20,000 shares, netting a total of over 1,500,610 in proceeds. Following the sale of shares at $75.03 each, the insider now holds 185,967 shares.
Before that, Huller Kelly had added 7,500 shares to its account. In a trade valued at $562,250, the Officer bought Globus Medical Inc shares for $74.97 each.
As published in a research note from Wells Fargo on August 07, 2024, Globus Medical Inc [GMED] has been rated up from an Equal weight to an Overweight and the price target has been revised to $78 from $60. Analysts at Piper Sandler upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in mid May. As of March 18, 2024, BTIG Research has increased its “Neutral” rating to a “Buy” for GMED. Earlier on October 20, 2023, ROTH MKM initiated its rating. Their recommendation was “a Buy” for GMED stock.
Analyzing GMED Stock Performance
During the last five days, there has been a drop of approximately -0.14%. Over the course of the year, Globus Medical Inc shares have jumped approximately 38.00%. Shares of the company reached a 52-week high of $75.98 on 10/16/24 and a 52-week low of $49.33 on 05/01/24. A 50-day SMA is recorded $71.44, while a 200-day SMA reached $63.15. Nevertheless, trading volume fell to 0.6 million shares from 0.86 million shares the previous day.
Support And Resistance Levels for Globus Medical Inc (GMED)
According to the 24-hour chart, there is a support level at 73.09, which, if violated, would cause prices to drop to 72.65. In the upper region, resistance lies at 74.35. The next price resistance is at 75.17. RSI (Relative Strength Index) is 55.19 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.62, which suggests the price will decrease in the coming days. Percent R is at 42.96%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
